MOLECULAR MECHANISMS IN RETINAL DEGENERATIONS
视网膜变性的分子机制
基本信息
- 批准号:6705056
- 负责人:
- 金额:$ 43.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-08-01 至 2006-01-31
- 项目状态:已结题
- 来源:
- 关键词:animal genetic material tagbiotechnologycone celldogselectroretinographyfluorescent in situ hybridizationfunctional /structural genomicsgene expressiongene mutationgenetic disordergenetic mappinggenetically modified animalsgreen fluorescent proteinshuman tissuelaboratory mousemessenger RNAmicroarray technologymolecular cloningmolecular pathologynorthern blottingsnucleic acid hybridizationnucleic acid probesnucleic acid sequenceretina degenerationrod cellyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): The long-term objectives of this
application are to isolate and characterize genes involved in inherited retina
degenerations affecting animals and humans, with emphasis on genes expressed in
cones, and to determine the function of the corresponding gene products. The
latter is essential if we want to understand the mechanism by which a disease
is produced and design paradigms to attempt its cure. To obtain genes expressed
in cones, we will take advantage of the cd dog that by adulthood has a retina
devoid of cones. We will use microarrays of the products of earlier rounds of
representational differences analysis (RDA) of normal and adult cd dog retina
cDNAs to find those cDNAs that are differentially expressed in normal and
cone-less retinas. Once we know the location of those cDNAs in human
chromosomes, we will determine the exon/intron boundaries of the corresponding
genes and screen them for mutations in the DNA of individuals affected with
cone dystrophies or related diseases. As examples of studies that we will carry
out in the future with the cone genes that we isolate, we will characterize and
determine the function of retinoschisin and Rp1, the protein products of the
Xlrs 1 and Rp1 genes, respectively. These genes, recently isolated in our
laboratory, cause retinoschisis and adRP. We will test the hypothesis that
after being secreted from photoreceptors, retinoschisin is taken up and
transported by Muller cells to the inner retina. We will also examine if once
in the inner retina retinoschisin is involved in cell adhesion, forming
complexes with proteins on the surface of other cells and maintaining in this
way the retina cytoarchitecture. With regards to the Rp1 gene, we successfully
introduced the human mutation R677X in the mouse Rp1 locus, obtained chimeric
animals, and determined that there is germ-line transmission of the mutant Rpl
allele in their progeny. We will now characterize the morphological and
physiological features of this new animal model of human RP1 disease during
development, and investigate how expression of the Rpl mutant gene is regulated
by oxygen in vivo. In addition, we will determine whether expression of the
mutated gene affects only the cells with the mutant allele or also the
neighboring wild-type cells in the retinas of Rpl chimeric animals. All of
these studies will use state-of-the-art methods in molecular biology, genetics,
cell biology and biochemistry, which are current in our laboratory.
描述(由申请人提供):本项目的长期目标
应用是分离和表征基因参与遗传性视网膜
退化影响动物和人类,重点是基因表达,
并确定相应基因产物的功能。的
如果我们想了解疾病发生的机制,后者至关重要
并设计了一些范例来尝试治愈它。为了获得表达的基因
在视锥细胞中,我们将利用成年后有视网膜的cd狗,
没有锥体。我们将使用前几轮产品的微阵列,
正常和成年cd狗视网膜的代表性差异分析(RDA)
目的是寻找那些在正常和非正常组织中差异表达的cDNA,
无视锥细胞视网膜一旦我们知道了这些cDNA在人体内的位置,
染色体,我们将确定相应的外显子/内含子边界
基因,并筛选他们的DNA突变的个人受影响,
视锥细胞营养不良或相关疾病。作为研究的例子,
在未来,我们分离出的视锥细胞基因,我们将描述,
确定视网膜裂素和Rp 1的功能,
Xlrs 1和Rp 1基因。这些基因,最近在我们的
实验室检查,导致视网膜劈裂和adRP。我们将检验这个假设,
在从光感受器分泌后,视网膜劈裂素被摄取,
通过Muller细胞运输到内部视网膜。我们还将检查是否有一次
在内层视网膜中,视网膜劈裂素参与细胞粘附,形成
与其他细胞表面的蛋白质形成复合物,
视网膜细胞结构的方式。关于Rp 1基因,我们成功地
在小鼠Rp 1基因座中引入人突变R677 X,获得嵌合的
动物,并确定有生殖系传播的突变Rpl
在他们的后代中。我们现在将描述形态学和
这一新的人类RP 1疾病动物模型的生理特征,
发展,并研究如何表达的Rpl突变基因的调控
体内的氧气。此外,我们将确定是否表达
突变基因只影响具有突变等位基因的细胞,或者也影响具有突变等位基因的细胞。
Rpl嵌合动物视网膜中邻近的野生型细胞。所有
这些研究将使用分子生物学,遗传学,
细胞生物学和生物化学,这是目前在我们的实验室。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEBORA B FARBER其他文献
DEBORA B FARBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEBORA B FARBER', 18)}}的其他基金
Stem Cell Microvesicles: Potential Tools for Retinal Regeneration
干细胞微泡:视网膜再生的潜在工具
- 批准号:
7360347 - 财政年份:2007
- 资助金额:
$ 43.27万 - 项目类别:
Stem Cell Microvesicles: Potential Tools for Retinal Regeneration
干细胞微泡:视网膜再生的潜在工具
- 批准号:
7534779 - 财政年份:2007
- 资助金额:
$ 43.27万 - 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
- 批准号:
6929014 - 财政年份:2003
- 资助金额:
$ 43.27万 - 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
- 批准号:
7084565 - 财政年份:2003
- 资助金额:
$ 43.27万 - 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
- 批准号:
6766784 - 财政年份:2003
- 资助金额:
$ 43.27万 - 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
- 批准号:
6702942 - 财政年份:2003
- 资助金额:
$ 43.27万 - 项目类别:
Pathfinding of Ganglion Cell Axons and Ocular Albinism
神经节细胞轴突与眼白化病的探路
- 批准号:
6417480 - 财政年份:2001
- 资助金额:
$ 43.27万 - 项目类别:
Pathfinding of Ganglion Cell Axons and Ocular Albinism
神经节细胞轴突与眼白化病的探路
- 批准号:
6525356 - 财政年份:2001
- 资助金额:
$ 43.27万 - 项目类别:
相似海外基金
Pioneering reproductive biotechnology innovations for equine breeding
开创马匹育种生殖生物技术创新
- 批准号:
LP230100156 - 财政年份:2024
- 资助金额:
$ 43.27万 - 项目类别:
Linkage Projects
Industrial Biotechnology Innovation Cluster
产业生物技术创新集群
- 批准号:
EP/Y024168/1 - 财政年份:2024
- 资助金额:
$ 43.27万 - 项目类别:
Research Grant
Environmental Biotechnology Innovation Centre
环境生物技术创新中心
- 批准号:
BB/Y008332/1 - 财政年份:2024
- 资助金额:
$ 43.27万 - 项目类别:
Research Grant
Shear Innovation: Valorising wool waste using biotechnology to enhance horticultural peat-free growing media
剪切创新:利用生物技术提高羊毛废料的价值,以增强园艺无泥炭生长介质
- 批准号:
10106787 - 财政年份:2024
- 资助金额:
$ 43.27万 - 项目类别:
Launchpad
Conference: Translating Molecular Science Innovations into Biotechnology Solutions
会议:将分子科学创新转化为生物技术解决方案
- 批准号:
2419731 - 财政年份:2024
- 资助金额:
$ 43.27万 - 项目类别:
Standard Grant
MFB: Partnerships to Transform Emerging Industries - RNA Tools/Biotechnology: Stabilizing Hairpin Inserts in RNA Virus Induced Gene Silencing Vectors
MFB:合作变革新兴产业 - RNA 工具/生物技术:稳定 RNA 病毒诱导基因沉默载体中的发夹插入
- 批准号:
2330663 - 财政年份:2024
- 资助金额:
$ 43.27万 - 项目类别:
Standard Grant
I-Corps: Translation potential of a miniaturized biotechnology platform for nucleic acid extraction, purification, and library preparation
I-Corps:用于核酸提取、纯化和文库制备的小型生物技术平台的转化潜力
- 批准号:
2421022 - 财政年份:2024
- 资助金额:
$ 43.27万 - 项目类别:
Standard Grant
NSF Convergence Accelerator Track M: Biofilm-based Corrosion Control using 3D Printed Biotechnology
NSF 融合加速器轨道 M:使用 3D 打印生物技术进行基于生物膜的腐蚀控制
- 批准号:
2344389 - 财政年份:2024
- 资助金额:
$ 43.27万 - 项目类别:
Standard Grant
Engineering Biology Hub for environmental processing and recovery of metals; from contaminated land to industrial biotechnology in a circular economy
用于环境处理和金属回收的工程生物中心;
- 批准号:
BB/Y008456/1 - 财政年份:2024
- 资助金额:
$ 43.27万 - 项目类别:
Research Grant
Conference: 2023 Chloroplast Biotechnology GRC & GRS: Harnessing the SynBio Revolution for Metabolic Engineering and Enhanced Photosynthesis
会议:2023年叶绿体生物技术GRC
- 批准号:
2243932 - 财政年份:2023
- 资助金额:
$ 43.27万 - 项目类别:
Standard Grant














{{item.name}}会员




